Carmell Therapeutics Corporation

NASDAQ (USD): Carmell Therapeutics Corporation (CTCX)

Last Price

0.386

Today's Change

+0.049 (14.54%)

Day's Change

0.362 - 0.437

Trading Volume

36,487,547

Overview

Market Cap

8 Million

Shares Outstanding

20 Million

Avg Volume

65,659

Avg Price (50 Days)

0.65

Avg Price (200 Days)

2.08

PE Ratio

-0.51

EPS

-0.76

Earnings Announcement

12-Nov-2024

Previous Close

0.34

Open

0.42

Day's Range

0.362 - 0.4372

Year Range

0.29 - 4.313

Trading Volume

36,491,355

Price Change Highlight

1 Day Change

14.47%

5 Day Change

7.50%

1 Month Change

-16.49%

3 Month Change

-77.31%

6 Month Change

-84.38%

Ytd Change

-89.90%

1 Year Change

-86.60%

3 Year Change

-96.03%

5 Year Change

-96.04%

10 Year Change

-96.04%

Max Change

-96.04%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment